Percutaneous ethanol injection is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation.
Gabriel Lazzarotto-da-SilvaTomaz J M Grezzana-FilhoLeandro A ScaffaroMauricio FarenzenaRafaela K SilvaAlexandre de AraujoSoraia ArrudaFlavia H FeierLucas PredigerGlória S LazzarettiMario R Alvares-da-SilvaAljamir D ChedidCleber R P KruelMarcio Fernandes ChedidPublished in: Langenbeck's archives of surgery (2023)
Dropout rates and post-transplant recurrence-free survivals related to PEI were comparable to those of TACE. This study supports the use of PEI alone or in combination with TACE for HCC patients awaiting OLT whenever RFA is not an option.